Targeted genome editing in acute lymphoblastic leukemia: a review

BACKGROUND: Genome editing technologies offers new opportunities for tackling diseases such as acute lymphoblastic leukemia (ALL) that have been beyond the reach of previous therapies. RESULTS: We show how the recent availability of genome-editing tools such as CRISPR-Cas9 are an important means of...

Descripción completa

Detalles Bibliográficos
Autores principales: Montaño, Adrián, Forero-Castro, Maribel, Hernández-Rivas, Jesús-María, García-Tuñón, Ignacio, Benito, Rocío
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050675/
https://www.ncbi.nlm.nih.gov/pubmed/30016959
http://dx.doi.org/10.1186/s12896-018-0455-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050675/
https://www.ncbi.nlm.nih.gov/pubmed/30016959
http://dx.doi.org/10.1186/s12896-018-0455-9

Ejemplares similares